Stago IVD, Liquid Anti-Xa, NDC 3607450003116. The STA - Liquid Anti-Xa kits are intended for use with STA-R, STA Compact and STA Satellite Analyzers for the quantitative determination of the plasma levels of unfractionated (UFH) and low molecular weight (LMWH) heparins by measuring their anti-Xa activity on antithrombin in a competitive assay using a synthetic chromogenic substrate.
Published September 24, 2014 · Recall initiated: July 18, 2014
Summary
FDA records medical device Class III recall Z-2650-2014, published September 24, 2014 and initiated July 18, 2014. Recalling firm: Diagnostica Stago, Inc.; Status: Terminated; Reported quantity: 514 kits; Lot: 510(k) #K111822, Lot #112366, Part # REF 00311US. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Diagnostica Stago Inc. received some customer complaints regarding a misreading of Reagent 1 (substrate) barcode on STA analyzers.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Diagnostica Stago, Inc.
- Distributor
- Distributed USA (nationwide) and the country of Canada.
- Lot
- 510(k) #K111822, Lot #112366, Part # REF 00311US
- Risk classification
- Class III
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDASTA Staclot Protein S, Model/Catalog Number: 00746-Reagent Lot number 273074; qualitative and quantitativeSeptember 9, 2026
- FDASTA-Liquid Anti-Xa 4. Model/Catalog Number: 00311US. The STA - Liquid Anti-Xa kits are intended for use withSeptember 3, 2025
- FDADiagnostica Stago STA N®oplastine® CI, 10 ml vial. In-Vitro Diagnostic for determination of the prothrombinSeptember 19, 2018
- FDANeoplastine® Cl Plus @ (ref.00374) Product Usage: Manual or automated determination of the prothrombin timeMarch 21, 2018
- FDAAXIOM Luminos dRF system with SW VD10 or on Luminos dRF Max The Axiom Luminos dRF is intended to be used as aSeptember 24, 2014
- FDACoulter DxH Diluent, Catalog No. 628017 Blood cell analysis comprises diluting a whole-blood sample with aSeptember 24, 2014
Questions about this recall
Was Stago IVD, Liquid Anti-Xa, NDC 3607450003116. The STA - Liquid Anti-Xa kits are intended for use with STA-R, STA Compact and STA Satellite Analyzers for the quantitative determination of the plasma levels of unfractionated (UFH) and low molecular weight (LMWH) heparins by measuring their anti-Xa activity on antithrombin in a competitive assay using a synthetic chromogenic substrate. recalled?
Yes. FDA published recall Z-2650-2014 on September 24, 2014. Reported hazard: Diagnostica Stago Inc. received some customer complaints regarding a misreading of Reagent 1 (substrate) barcode on STA analyzers.
What should I do if I have this product?
Voluntary: Firm initiated · Letter